Skip to content

Effect of Scaling and Root Planing on Liver Function Test (Alanine Aminotransferase and Aspartate Aminotransferase) in Systemically Healthy - Chronic Periodontitis Subjects: a Clinical Trial.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02583841
Enrollment
50
Registered
2015-10-22
Start date
2015-02-28
Completion date
2015-03-31
Last updated
2015-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis (CP) Subjects.

Brief summary

Aim: To evaluate effect of non- surgical periodontal therapy on liver function in systemically healthy chronic periodontitis (CP) subjects. Materials and methods: The study is non surgical interventional trial, includes 50 CP subjects in the age group of 35- 60 years selected from the OPD (Out Patient Department) of department of periodontology Tatyasaheb Kore Dental College and Research center (TKDC and RC), Kolhapur. CP subjects were equally divided into test group and control group. Liver function test- aspartate aminotransferase (AST), alanine aminotransferase (ALT) were checked at baseline and at 1 month after treatment. Clinical examination includes plaque index, gingival index, sulcus bleeding index, probing depth, clinical attachment loss.

Interventions

PROCEDUREScaling and root planing

scaling and root planing as an intervention was done in patients of the test group

Sponsors

Tatyasaheb Kore Dental College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. Subjects with CP (moderate and severe) as per Centers for disease control and prevention (CDC) criteria 2007. 2. Patients without any known systemic diseases \-

Exclusion criteria

1. Patients who have taken anti-inflammatory/antibiotic/antioxidant within 3 months of beginning of study. 2. Subjects who have undergone periodontal treatment within six months of inception of study. 3. Smokers, tobacco habits in any form and alcoholics. 4. Pregnant and lactating women. \-

Design outcomes

Primary

MeasureTime frame
Alanine aminotransferase1month
Aspartate aminotransferase1 month

Secondary

MeasureTime frame
sulcus bleeding index1month
plaque index1month
Clinical attachment loss1 month
probing depth1month
gingival index1 month

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026